secwatch.observer — SEC 8-K summary
======================================

Issuer:     Verrica Pharmaceuticals Inc. (VRCA)
CIK:        0001660334
Form:       8-K
Filed at:   2022-09-14T23:59:59+00:00
Accession:  0001193125-22-244283
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Verrica posts updated corporate presentation; no material details provided in filing
--------------------------------------------------------------------------------

- Filing under Item 7.01 Regulation FD discloses updated corporate presentation posted on company website.
- Exhibit 99.1 consists only of a cover page; no specific financial or strategic updates are included in the filing.
- Presentation may contain operational updates, but content is not summarized in this 8-K.
- No changes to guidance, pipeline, or financials are explicitly stated.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1660334/000119312522244283/0001193125-22-244283-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1660334/000119312522244283/d356833d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-244283

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer